Pharmafile Logo

dual tasking

- PMLiVE

Teva plans revamp as 2013 revenues expected to fall short

Expects increased competition for biggest-selling drug Copaxone

- PMLiVE

Pharma R&D costs up tenfold since 1970s

Average cost to bring a drug to market now $1.9bn, according to the Office for Health Economics

- PMLiVE

Gorsky named chairman of J&J

Completes transition from former CEO and chair Bell Weldon

- PMLiVE

Genzyme makes Brendan Martin UK and Ireland manager

Replaces Paul Drohan who returns to Canada

- PMLiVE

FDA approves Exelixis’ Cometriq for rare thyroid cancer

Genomics-based discovery company also submits the drug to EU regulators

- PMLiVE

RSA appoints Michael Huberts as executive search consultant

He joins from Tokyo-based executive search firm Optia Partners

- PMLiVE

Talent management: Taking the blinkers off

The struggle to find talented staff shows no sign of abating but there are steps that can and should be taken to alleviate the problem

- PMLiVE

Sanofi takes anti-counterfeiting message to the skies

Hopes to reach four million passengers with Air France film

- PMLiVE

Streaming Well and Terrence Higgins Trust launch HIV education series

Online videos target young people in Britain

- PMLiVE

Efforts to curb HIV must be stepped up, says report

HIV/AIDS advocacy group ONE pushes for more funding to end epidemic

- PMLiVE

Merck withdraws filing for sarcoma drug in Europe

Oncology setback sees ridaforolimus licence application pulled

- PMLiVE

Trio of wins for Leo Pharma at PMEA

Takes small company of the year, launch excellence and patient services awards

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links